National Blood Clot Alliance Named as an Official Charity Partner of the 2015 TCS New York City Marathon

Nearly 300 official charity partners are expected to participate in the 2015 TCS New York City Marathon this year. The National Blood Clot Alliance has ten available spots on their Team Stop the Clot® this year.

The National Blood Clot Alliance (NBCA) announced today that it will be an Official Charity Partner of the 2015 TCS New York City Marathon when the race takes place on Sunday, November 1, 2015.

“We are very excited about this great opportunity,” says NBCA CEO Randy Fenninger, "as the TCS New York City Marathon provides a powerful platform for our passionate runners on Team Stop the Clot® to raise funds and awareness about life-threatening blood clots.”

We are very excited about this great opportunity, as the TCS New York City Marathon provides a powerful platform for our passionate runners on Team Stop the Clot® to raise funds and awareness about life-threatening blood clots.

Randy Fenninger, NBCA CEO

Nearly 300 official charity partners are expected to participate in the 2015 TCS New York City Marathon this year. The National Blood Clot Alliance has ten available spots on their Team Stop the Clot® this year. All Team Stop the Clot® marathoners have the opportunity to raise awareness and help save lives, while running one of the world’s greatest road races.

Up to 900,000 people in the United States each year are affected by blood clots in their legs (deep vein thrombosis or DVT) and blood clots in their lungs (pulmonary embolism or PE). Annually, up to 300,000 Americans – or one person in this country every six minutes – will die due to a blood clot. Blood clots do not discriminate. They affect men, women and children, regardless of race, ethnicity, and age. Also, DVT/PE is not just limited to the elderly or infirmed. Blood clots strike even the fittest athletes.

All Team Stop The Clot® members running in the 2015 TCS New York City Marathon are provided with special amenities, including: A Stop The Clot® racing singlet, a race weekend brunch, and fundraising assistance. Team Stop the Clot® members are required to raise a minimum of $2500.

“We warmly welcome the National Blood Clot Alliance as an official charity partner for the 2015 TCS New York City Marathon,” said Mary Wittenberg, president and CEO of New York Road Runners. “All of our participants are inspired to run for reasons significant and special to them, and we are especially appreciative of those who make a meaningful commitment to run on behalf of one of our official charity partners. We wish the best to all of these runners as they begin to plan and prepare for an experience of a lifetime at the 2015 TCS New York City Marathon.”

The 2015 TCS New York City Marathon will feature a talented American and international professional athlete field, charity runners, and thousands of runners of all ages and abilities. More than 10,000 volunteers help to support participants across the 26.2-mile race route, which touches each of New York City’s five boroughs, and is lined with more than one million neighbors and guests. Last year, NYRR celebrated each of the 50,530 runners who crossed the finish line and made the 2014 TCS New York City Marathon the largest in the world, including the one-millionth finisher ever in the history of the event. Participants hailed from more than 130 countries and each of the 50 states. The 2015 TCS New York City Marathon will again air live locally on ABC7 and nationally on ESPN2.

NBCA Mission

The National Blood Clot Alliance is dedicated to advancing the prevention, early diagnosis and successful treatment of life-threatening blood clots, such as deep vein thrombosis, pulmonary embolism, and clot-provoked stroke. NBCA works on behalf of people who may be susceptible to blood clots, including, but not limited to, people with clotting disorders, atrial fibrillation, cancer, traumatic injury, and risks related to surgery, lengthy immobility, child birth and birth control. NBCA accomplishes its mission through programs that build public awareness, educate patients and healthcare professionals, and promote supportive public and private sector policy.  To learn more about blood clots, visit www.stoptheclot.org or follow NBCA on Twitter or Facebook.

About the TCS New York City Marathon

The TCS New York City Marathon is the premier event of New York Road Runners (NYRR) and the largest marathon in the world. Held annually on the first Sunday in November, the race features the world’s top professional athletes and a vast range of competitive, recreational, and charity runners. The race began in 1970 with just 127 entrants running four laps around Central Park, and expanded citywide in 1976. In 2014, a record 50,530 runners from 130 countries toured New York City’s five boroughs, starting on Staten Island at the foot of the Verrazano-Narrows Bridge, and running through the neighborhoods of Brooklyn, Queens, and the Bronx, before ending in Manhattan at the iconic Central Park finish line. More than one million spectators line the city streets to cheer on the runners, while millions more watch the live television broadcast in the United States and around the world. The race is part of the Abbott World Marathon Majors, a series featuring the world’s top marathons—Tokyo, Boston, London, Berlin, Chicago, and New York—and crowning the top professional male and female marathoners of the series. Tata Consultancy Services (TCS), a leading global IT services, consulting, and business solutions organization, is the premier partner of NYRR and the title sponsor of the TCS New York City Marathon. To learn more, visit www.tcsnycmarathon.com.

For more information, contact Judi Elkin at [email protected] or 617.529.1054.

Share:


Tags: blood clots, deep vein thrombosis, DVT, PE, pulmonary embolism, TCS New York City Marathon


About National Blood Clot Alliance

View Website

NBCA is a non-profit, voluntary health organization dedicated to advancing the prevention, early diagnosis and successful treatment of life-threatening blood clots such as deep vein thrombosis, pulmonary embolism, and clot-provoked stroke.